Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$600,000.00
Apr 1, 2012
Using the zebrafish as a pre-clinical animal tumour model for drug discovery and the evaluation of anti-leukemia agents
$290,176.00
Apr 1, 2012
Early phase clinical trials with the small molecule DCA in Pulmonary Arterial Hypertension
$776,835.00
Apr 1, 2012
Severe influenza in infants, children and youths: Role of clinical and epidemiologic risk factors
$493,169.00
Apr 1, 2012
The Role of microRNAs in Renal Cell Carcinoma Pathogenesis and their Clinical Utility as Tumor Markers
$110,000.00
Apr 1, 2012
Ex Vivo IL-10 Gene Therapy in a Pre-Clinical Lung Transplantation Survival Model
$297,244.00
Apr 1, 2012
Phase II clinical trial of pantoprazole and docetaxel for men with metastatic castration-resistant prostate cancer
$165,077.00
Apr 1, 2012
Clinical Outcomes and Cost-Effectiveness of Walk-In Counselling Clinics: A Controlled Study
$347,338.00
Apr 1, 2012
Strategic configuration of cancer care services based on clinical, demographic and geographic considerations
$472,096.00
Apr 1, 2012
Completion of the Derivation of a Clinical Decision Rule to Predict Mobility Decline among Independent Seniors with Minor Injuries in the Emergency Department (Phase 1B)
$140,000.00
Apr 1, 2012
Advancing Tumour Infiltrating Lymphocyte Therapy for Ovarian Cancer to the Clinic